JACC: CardioOncology - The Ticagrelor-Oncology (TICONC) Study: Implications of P2Y12 Inhibition for Metastasis and Cancer-Associated Thrombosis
Episode Description
Commentary by Dr. Paul Burridge
We use cookies to run this site. Analytics cookies, which show us how it's used, stay off unless you accept them. Change your mind any time with the cookie button at the bottom right. How we use cookies